| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/15/2007 | US20070061912 Method for obtaining improved fertility restorer lines for transgenic male sterile crop plants and a dna construct for use in said method |
| 03/15/2007 | US20070061911 Polynucleotides and polypeptides in plants |
| 03/15/2007 | US20070061910 Method for culturing avian spermatogonial stem cells and avian spermatogonial stem cells prepared thereby |
| 03/15/2007 | US20070061908 Transgenic animal for screening therapeutic agents for brain tumors |
| 03/15/2007 | US20070061907 Inhibitor of differentiation knockout mammals and methods of use thereof |
| 03/15/2007 | US20070061906 Human T2R75 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061905 screening mammalian chemosensory G Protein-Coupled Receptors active in taste signaling; genes and cDNA encoding such receptors |
| 03/15/2007 | US20070061904 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070061903 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste |
| 03/15/2007 | US20070061902 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/15/2007 | US20070061901 Methods to inhibit growth of prostate cancer cells |
| 03/15/2007 | US20070061900 Methods of modifying eukaryotic cells |
| 03/15/2007 | US20070061086 Cardiotoxin molecular toxicology modeling |
| 03/15/2007 | US20070060742 for new human tumor necrosis factor receptor designated as Ztnfr12; usefulness in both basic research and as therapeutics |
| 03/15/2007 | US20070060643 Autoinducer compounds |
| 03/15/2007 | US20070060539 Shc proteins as therapeutic targets in proliferative diseases |
| 03/15/2007 | US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/15/2007 | US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/15/2007 | US20070059836 Genetic engineering; preventing the proliferation of neoplastic cells; cancer; |
| 03/15/2007 | US20070059835 Ocular gene therapy using avalanche-mediated transfection |
| 03/15/2007 | US20070059834 Method for treating small volumes with electrical current |
| 03/15/2007 | US20070059833 Use of Nucleases to Improve Viability and Enhance Transgene Expression in Transfected Cells |
| 03/15/2007 | US20070059832 by electroporation; efficient introduction of a gene into cells, gene introduction at desirable timing and at desirable sites can be performed without damaging the adhering cells |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059830 Method for creating myeloid cell lines |
| 03/15/2007 | US20070059828 Carrier for nucleic acid molecule delivery |
| 03/15/2007 | US20070059825 Cytokine zalpha11 ligand antibodies |
| 03/15/2007 | US20070059820 Lentivector constructs for expression of recombinant proteins, polypeptides or fragments thereof; have self-processing cleavage sequence between first and second protein or polypeptide coding sequence allowing for expression of functional protein or polypeptide under operative control of single promoter |
| 03/15/2007 | US20070059811 Endogenous polynucleotide which encodes glycerol kinase has been inactivated; Pantoea cultured in presence of fructose; genetically engineered to have uncoupled productive and catabolic pathways |
| 03/15/2007 | US20070059810 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 03/15/2007 | US20070059809 Corynebacterium glutamicum genes encoding regulatory proteins |
| 03/15/2007 | US20070059806 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 03/15/2007 | US20070059805 Method for producing saccharide chain-extended chondroition |
| 03/15/2007 | US20070059802 Polypeptides and nucleic acids derived from S. pneumoniae that are useful as reagents for diagnosis of bacterial infection, components of effective antibacterial vaccines, and/or as targets for antibacterial drugs; genetic enginnering; nucleotide sequences; binding mRNA to block protein translation |
| 03/15/2007 | US20070059801 Recombinant expression vector comprising nucleic acid linked to transcription regulatory element; prophylaxis and treatment of bacterial infections |
| 03/15/2007 | US20070059800 Novel peptide, novel adsorbent, adsorption unit and adsorption method |
| 03/15/2007 | US20070059797 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 03/15/2007 | US20070059794 Chaperonin-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release formulation, and method of producing antibody against target protein |
| 03/15/2007 | US20070059793 Nogo receptor binding protein |
| 03/15/2007 | US20070059790 Method to increase carotenoid production in a microbial host cell by down-regulating glycogen synthase |
| 03/15/2007 | US20070059768 Broad host range vectors for shotgun and expression library cloning in Gram negative bacteria |
| 03/15/2007 | US20070059767 Method of identifying N-terminal proBNP |
| 03/15/2007 | US20070059759 Human T2R63 receptor and related assays for identifying human bitter taste modulators |
| 03/15/2007 | US20070059758 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
| 03/15/2007 | US20070059755 Screening peptide library; incubation; complexing |
| 03/15/2007 | US20070059750 Identifier and nucleic acid amplification method of verification using the same |
| 03/15/2007 | US20070059744 Corynebacterium glutamicum genes encoding novel proteins |
| 03/15/2007 | US20070059737 Gene expression profiling in biopsied tumor tissues |
| 03/15/2007 | US20070059734 Reagent for detecting biopolymer and method for detecting biopolymer |
| 03/15/2007 | US20070059733 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups |
| 03/15/2007 | US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 03/15/2007 | US20070059721 MAGI polynucleotides, polypeptides, and antibodies |
| 03/15/2007 | US20070059713 SSB-DNA polymerase fusion proteins |
| 03/15/2007 | US20070059706 Materials and methods relating to breast cancer classification |
| 03/15/2007 | US20070059703 Genome mapping of functional dna elements and cellular proteins |
| 03/15/2007 | US20070059702 Disease related protein network |
| 03/15/2007 | US20070059692 Array oligomer synthesis and use |
| 03/15/2007 | US20070059690 "Met/fret based method of target nucleic acid detection whereby the donor/acceptor moieties are on complementary strands" |
| 03/15/2007 | US20070059689 Hybrid glycosylated products and their production and use |
| 03/15/2007 | US20070059688 Gastrointestinal chemosensory receptors |
| 03/15/2007 | US20070059684 Method of identifying an antiviral agent |
| 03/15/2007 | US20070059353 Polyarginine-modified liposome having nuclear entry ability |
| 03/15/2007 | US20070059326 Escherichia coli-derived vaccine and therapy against botulism |
| 03/15/2007 | US20070059325 Genetic vaccine against PWD circovirus |
| 03/15/2007 | US20070059324 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/15/2007 | US20070059323 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof |
| 03/15/2007 | US20070059322 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines |
| 03/15/2007 | US20070059309 Culturing a host cell transformed with a nucleic acid encoding murine anti-human IFN- alpha monoclonal antibody 9F3; culture product neutralizes all seven of recombinant human IFN- alpha subtypes tested; diseases involving cell overexpression; autoimmune diseases; antidiabetic agents; lupus (SLE) |
| 03/15/2007 | US20070059307 Biological products |
| 03/15/2007 | US20070059305 Neutralizing human anti-IGFR antibody |
| 03/15/2007 | US20070059303 monoclonal antibody for prevention and treatment of allergies, asthma, crohn's and lymes disease, arthritis, diabetes, glomerularnephritis, vision defects, skin disorders, sarcoidosis and viral diseases |
| 03/15/2007 | US20070059299 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 03/15/2007 | US20070059291 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV) |
| 03/15/2007 | US20070059290 Transcriptional regulation of target genes |
| 03/15/2007 | US20070059287 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
| 03/15/2007 | US20070059286 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
| 03/15/2007 | US20070059282 Immunocytokine sequences and uses thereof |
| 03/15/2007 | US20070059271 polyethylene glycol/poly( beta -benzyl-L-aspartate)-ac block copolymer; useful as carrier for in vivo delivery of active substances such as DNA; enables provision of PIC micelles having higher gene transfer effectivity |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | DE102005043327A1 Verfahren zur Herstellung von festen Enzymgranulaten für Futtermittel A process for the production of solid enzyme granules for feed |
| 03/15/2007 | DE102005043325A1 Enzymhaltige Granulate für Futtermittel Enzyme-containing granules for feedingstuffs |
| 03/15/2007 | DE102005043324A1 Phytasehaltiges Enzymgranulat II Phytase enzyme granules II |
| 03/15/2007 | DE102005043323A1 Phytasehaltiges Enzymgranulat I Phytase enzyme granulate I |
| 03/15/2007 | DE102005043152A1 Alkoholdehydrogenase aus Nocardia globerula und deren Verwendung Alcohol dehydrogenase from Nocardia globerula and their use |
| 03/15/2007 | CA2808659A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 03/15/2007 | CA2808179A1 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 03/15/2007 | CA2648516A1 Abiotic stress tolerant gene from avicennia marina encoding a protein |
| 03/15/2007 | CA2638831A1 Glutathione-s-transferase gene from prosopis juliflora confers abiotic stress tolerance in plants |
| 03/15/2007 | CA2624966A1 Deregulated bacteria with improved polyhydroxyalkanoate production |
| 03/15/2007 | CA2621982A1 Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
| 03/15/2007 | CA2621973A1 Chimeric hcn channels |
| 03/15/2007 | CA2621922A1 Dna sequences involved in prenylflavonoid biosynthesis in hops and their use in modifying prenylflavonoid production in plants |
| 03/15/2007 | CA2621874A1 Plants modified with mini-chromosomes |
| 03/15/2007 | CA2621764A1 Method for preparing trimeric proteins |
| 03/15/2007 | CA2621694A1 Pharmaceutical compositions for delivery of ribonucleic acid to a cell |
| 03/15/2007 | CA2621562A1 Methods and organisms for the growth-coupled production of succinate |
| 03/15/2007 | CA2621536A1 A transgenic plant having enhanced drought tolerance |
| 03/15/2007 | CA2621482A1 Lopap-based pharmaceutical compositions and uses thereof |
| 03/15/2007 | CA2621414A1 Mmp-7 and adf derived tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules |
| 03/15/2007 | CA2621394A1 Vectors and methods for improved plant transformation efficiency |